{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:33Z","timestamp":1794324573225,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12028-019-00781-w","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:02:43Z","timestamp":1562864563000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Dysautonomia in Guillain\u2013Barr\u00e9 Syndrome: Prevalence, Clinical Spectrum, and Outcomes"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-8592","authenticated-orcid":false,"given":"Tia","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco F. M.","family":"Wijdicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"3","key":"781_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","volume":"92","author":"EF Wijdicks","year":"2017","unstructured":"Wijdicks EF, Klein CJ. Guillain\u2013Barre syndrome. Mayo Clin Proc. 2017;92(3):467\u201379.","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"781_CR2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/brain\/120.10.1885","volume":"120","author":"P Flachenecker","year":"1997","unstructured":"Flachenecker P, Hartung HP, Reiners K. Power spectrum analysis of heart rate variability in Guillain\u2013Barr\u00e9 syndrome. A longitudinal study. Brain. 1997;120(10):1885\u201394.","journal-title":"Brain"},{"issue":"11","key":"781_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/jnnp.44.11.983","volume":"44","author":"RR Tuck","year":"1981","unstructured":"Tuck RR, McLeod JG. Autonomic dysfunction in Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry. 1981;44(11):983\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"781_CR4","first-page":"161","volume":"30","author":"A Guz","year":"1966","unstructured":"Guz A, et al. The role of vagal and glossopharyngeal afferent nerves in respiratory sensation, control of breathing and arterial pressure regulation in conscious man. Clin Sci. 1966;30(1):161\u201370.","journal-title":"Clin Sci"},{"issue":"2","key":"781_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s001150050414","volume":"70","author":"G Pfeiffer","year":"1999","unstructured":"Pfeiffer G. Dysautonomia in Guillain\u2013Barre syndrome. Nervenarzt. 1999;70(2):136\u201348.","journal-title":"Nervenarzt"},{"key":"781_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-216757","author":"S Nabi","year":"2016","unstructured":"Nabi S, et al. Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain\u2013Barre\u2019 syndrome (GBS). BMJ Case Rep. 2016. \nhttps:\/\/doi.org\/10.1136\/bcr-2016-216757\n\n.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"781_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0976-3147.127877","volume":"5","author":"BF Banakar","year":"2014","unstructured":"Banakar BF, et al. Guillain\u2013Barre syndrome with posterior reversible encephalopathy syndrome. J Neurosci Rural Pract. 2014;5(1):63\u20135.","journal-title":"J Neurosci Rural Pract"},{"key":"781_CR8","volume-title":"Guillain\u2013Barr\u00e9 syndrome. Contemporary neurology series","author":"AH Ropper","year":"1991","unstructured":"Ropper AH, Wijdicks EFM, Truax BT. Guillain\u2013Barr\u00e9 syndrome. Contemporary neurology series. F.A. Davis: Philadelphia; 1991."},{"issue":"2","key":"781_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-0404.1987.tb07902.x","volume":"75","author":"NK Singh","year":"1987","unstructured":"Singh NK, et al. Assessment of autonomic dysfunction in Guillain\u2013Barre syndrome and its prognostic implications. Acta Neurol Scand. 1987;75(2):101\u20135.","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"781_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s004150050506","volume":"246","author":"G Pfeiffer","year":"1999","unstructured":"Pfeiffer G, et al. Indicators of dysautonomia in severe Guillain\u2013Barre syndrome. J Neurol. 1999;246(11):1015\u201322.","journal-title":"J Neurol"},{"issue":"7","key":"781_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R van Koningsveld","year":"2007","unstructured":"van Koningsveld R, et al. A clinical prognostic scoring system for Guillain\u2013Barre syndrome. Lancet Neurol. 2007;6(7):589\u201394.","journal-title":"Lancet Neurol"},{"issue":"12","key":"781_CR12","first-page":"1499","volume":"70","author":"SE Hocker","year":"2013","unstructured":"Hocker SE, et al. Indicators of central fever in the neurologic intensive care unit. JAMA Neurol. 2013;70(12):1499\u2013504.","journal-title":"JAMA Neurol"},{"issue":"11","key":"781_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S1474-4422(15)00257-4","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA. The diagnosis of posterior reversible encephalopathy syndrome\u2014authors\u2019 reply. Lancet Neurol. 2015;14(11):1075.","journal-title":"Lancet Neurol"},{"issue":"8093","key":"781_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750\u20133.","journal-title":"Lancet"},{"issue":"24","key":"781_CR15","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain\u2013Barre syndrome. N Engl J Med. 2012;366(24):2294\u2013304.","journal-title":"N Engl J Med"},{"issue":"4","key":"781_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s100720070081","volume":"21","author":"Guillain\u2013Barre Syndrome Study Group","year":"2000","unstructured":"Guillain\u2013Barre Syndrome Study Group. Guillain\u2013Barre syndrome: an Italian multicentre case-control study. Neurol Sci. 2000;21(4):229\u201334.","journal-title":"Neurol Sci"},{"issue":"10","key":"781_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/mus.880171004","volume":"17","author":"DW Zochodne","year":"1994","unstructured":"Zochodne DW. Autonomic involvement in Guillain\u2013Barre syndrome: a review. Muscle Nerve. 1994;17(10):1145\u201355.","journal-title":"Muscle Nerve"},{"issue":"5","key":"781_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jnnp.51.5.605","volume":"51","author":"JB Winer","year":"1988","unstructured":"Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51(5):605\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"781_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-194902010-00003","volume":"28","author":"WE Haymaker","year":"1949","unstructured":"Haymaker WE, Kernohan JW. The Landry\u2013Guillain\u2013Barre syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore). 1949;28(1):59\u2013141.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"781_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/0002-9343(71)90185-9","volume":"50","author":"P Lichtenfeld","year":"1971","unstructured":"Lichtenfeld P. Autonomic dysfunction in the Guillain\u2013Barre syndrome. Am J Med. 1971;50(6):772\u201380.","journal-title":"Am J Med"},{"issue":"9","key":"781_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF03030974","volume":"146","author":"CP Bredin","year":"1977","unstructured":"Bredin CP. Guillain\u2013Barre syndrome: the unsolved cardiovascular problems. Ir J Med Sci. 1977;146(9):273\u20139.","journal-title":"Ir J Med Sci"},{"issue":"1\u20132","key":"781_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0022-510X(78)90234-4","volume":"37","author":"D Soffer","year":"1978","unstructured":"Soffer D, Feldman S, Alter M. Clinical features of the Guillain\u2013Barre syndrome. J Neurol Sci. 1978;37(1\u20132):135\u201343.","journal-title":"J Neurol Sci"},{"issue":"8","key":"781_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archinte.1980.00330190065021","volume":"140","author":"P Greenland","year":"1980","unstructured":"Greenland P, Griggs RC. Arrhythmic complications in the Guillain\u2013Barre syndrome. Arch Intern Med. 1980;140(8):1053\u20135.","journal-title":"Arch Intern Med"},{"issue":"7","key":"781_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/mus.1095","volume":"24","author":"TM Burns","year":"2001","unstructured":"Burns TM, et al. Adynamic ileus in severe Guillain\u2013Barre syndrome. Muscle Nerve. 2001;24(7):963\u20135.","journal-title":"Muscle Nerve"},{"issue":"3","key":"781_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10286-018-0542-y","volume":"29","author":"Z Zaeem","year":"2019","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain\u2013Barre syndrome: an update. Clin Auton Res. 2019;29(3):289\u201399.","journal-title":"Clin Auton Res"},{"issue":"2","key":"781_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/mus.25551","volume":"56","author":"C Anandan","year":"2017","unstructured":"Anandan C, Khuder SA, Koffman BM. Prevalence of autonomic dysfunction in hospitalized patients with Guillain\u2013Barre syndrome. Muscle Nerve. 2017;56(2):331\u20133.","journal-title":"Muscle Nerve"},{"issue":"4","key":"781_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1385\/NCC:1:4:465","volume":"1","author":"A Elahi","year":"2004","unstructured":"Elahi A, Kelkar P, St Louis EK. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain\u2013Barre Syndrome. Neurocrit Care. 2004;1(4):465\u20138.","journal-title":"Neurocrit Care"},{"issue":"1","key":"781_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clineuro.2006.01.004","volume":"109","author":"D Van Diest","year":"2007","unstructured":"Van Diest D, et al. Posterior reversible encephalopathy and Guillain\u2013Barre syndrome in a single patient: coincidence or causative relation? Clin Neurol Neurosurg. 2007;109(1):58\u201362.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"781_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mus.880150103","volume":"15","author":"JG McLeod","year":"1992","unstructured":"McLeod JG. Invited review: autonomic dysfunction in peripheral nerve disease. Muscle Nerve. 1992;15(1):3\u201313.","journal-title":"Muscle Nerve"},{"issue":"1","key":"781_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1034\/j.1600-0404.2002.00099.x","volume":"105","author":"M Asahina","year":"2002","unstructured":"Asahina M, et al. Autonomic function in demyelinating and axonal subtypes of Guillain\u2013Barre syndrome. Acta Neurol Scand. 2002;105(1):44\u201350.","journal-title":"Acta Neurol Scand"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-019-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-019-00781-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-019-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T16:38:26Z","timestamp":1600274306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-019-00781-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s12028-019-00781-w","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"11 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Support"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Mayo Clinic Institutional Review Board approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}